Table 2. Distribution of prognostic factors according to delay form diagnosis to surgery (percentages in brackets).
| Characteristic | P-value | <21 days (n=84) | 22–42 days (n=164) | 43–63 days(n=210) | >64 days (n=174) |
|---|---|---|---|---|---|
| Age (years) | 0.0255 | ||||
| <60 | 31 (36.9) | 54 (32.9) | 49 (23.3) | 37 (21.3) | |
| 60–70 | 24 (28.6) | 62 (37.8) | 80 (38.1) | 63 (36.2) | |
| >70 | 29 (34.5) | 48 (29.3) | 81 (38.6) | 74 (42.5) | |
| Gender | 0.3681 | ||||
| Male | 54 (64.3) | 123 (75) | 149 (71) | 125 (71.8) | |
| Female | 30 (35.7) | 41 (25) | 61 (29) | 49 (28.2) | |
| Hospital type | <0.0001 | ||||
| UHs | 31 (36.9) | 74 (45.1) | 107 (51) | 115 (66) | |
| DGHs | 45 (53.6) | 84 (51.2) | 101 (48.1) | 58 (33.4) | |
| PrHs | 8 (9.5) | 6 (3.7) | 2 (0.9) | 1 (0.6) | |
| Tumour location | 0.054 | ||||
| Upper/middle | 15 (17.9) | 19 (11.6) | 27 (12.9) | 14 (8.1) | |
| Lower | 35 (41.7) | 54 (32.9) | 69 (32.9) | 52 (29.9) | |
| OGJ | 32 (38) | 81 (49.4) | 107 (50.9) | 104 (59.8) | |
| Not specified | 2 (2.4) | 10 (6.1) | 7 (3.3) | 4 (2.2) | |
| Histology | 0.0008 | ||||
| AC | 54 (64.3) | 118 (72) | 154 (73.3) | 149 (85.6) | |
| SCC | 30 (35.7) | 46 (28) | 56 (26.7) | 25 (14.4) | |
| Tumour grade | 0.1699 | ||||
| WD | 7 (8.4) | 13 (7.9) | 15 (7.1) | 23 (13.2) | |
| MD | 37 (44) | 64 (39) | 81 (38.6) | 55 (31.6) | |
| PD | 39 (46.4) | 77 (47) | 103 (49.1) | 81 (46.6) | |
| Not specified | 1 (1.2) | 10 (6.1) | 11 (5.2) | 15 (8.6) | |
| Lymph-node status | 0.0556 | ||||
| LN −ve | 32 (38.1) | 41 (25) | 70 (33.3) | 68 (39.1) | |
| LN +ve | 52 (61.9) | 123 (75) | 137 (65.3) | 104 (59.7) | |
| Not specified | 0 | 0 | 3 (1.4) | 2 (1.1) | |
| Resection | 0.0097 | ||||
| R0 | 55 (65.5) | 99 (60.4) | 153 (72.9) | 125 (71.8) | |
| R1/2 | 28 (33.3) | 63 (38.4) | 49 (23.3) | 41 (23.6) | |
| Not specified | 1 (1.2) | 2 (1.2) | 8 (3.8) | 8 (4.6) | |
| Postoperative mortality | 0.9716 | ||||
| 30-day | 11 (13) | 19 (11.6) | 24 (11.4) | 22 (12.6) | |
| 90-day | 16 (19) | 33 (20.1) | 37 (17.6) | 32 (18.4) |
Abbreviations: AC, adenocarcinoma; DGH, district general hospital; LN, lymph node; OGJ, oesophagogastric junction; Prh, private hospital; SCC, squamous cell carcinoma; UH, university hospitals.
Significant P-values in bold.